A systematic review platform, built by systematic reviewers for their own reviews.

We run our own living review on it every week. It follows the methods you'll be asked about, it's careful with AI, and when you re-run your search, your team's decisions are already there.

Built and run on the SLEEPI insomnia project, currently managing 450+ trials.
Title and abstract screening screen: one record with highlighted eligibility terms and Include / Exclude buttons

Three things we hold to.

The same things a peer reviewer or guideline panel will ask about your review.

01

Follows the methods

Independent dual screening, a dedicated step for resolving disagreements, and a PRISMA 2020 flow that counts itself. Every decision records who made it and when. Structured risk-of-bias assessment runs on a template you upload — your own domains, signalling questions and judgment rules.

Conflict resolution screen: two reviewers' opposite decisions on the same record, side by side
02

Careful with AI

The ranking model only changes the order you see records in — the model never records a decision for you. An experimental AI screening assistant runs only in projects we have approved, currently just our own, and at title/abstract no record is excluded without a human reviewer's judgement. We add AI only after testing it against human decisions.

Decision log: each screening decision listed with the reviewer who made it and when
03

Ready when you re-run the search

Update the search before submission, for a revision, or every year: records you already screened stay screened, and only new ones enter the queue. New results are matched against every earlier round, and the PRISMA flow is rebuilt from the same records. A living review is just that, repeated.

PRISMA 2020 flow diagram generated from the screening records

One review, round after round.

Round 1 is a standard systematic review. When you search again, every earlier decision is still there, and only the new records need your team.

ROUND 1 Import Deduplicate Screen ×2 Resolve Extract PRISMA 2020 two independent reviewers ROUND 2 search again New search Deduplicate Match earlierrounds New records → Screen ×2 Already screened: decision kept
  1. Round 1. Import → deduplicate → two independent reviewers screen → resolve disagreements → extract → PRISMA 2020 flow.
  2. Round 2. Search again. New results are matched against earlier rounds: records already screened keep their decisions, and only new records go to dual screening.
Portrait of Yuki Furukawa
Built by · Practicing systematic reviewer

Psychiatrist specializing in insomnia. Lead of the SLEEPI project — a Living Systematic Review of psychological interventions for insomnia, in its 5th update round as of September 2026, with 450+ randomized trials.

SLEEPI started as our living review of insomnia treatments; the platform grew out of it. Every feature ships because that review needed it — not because a roadmap said so.

Publications from the SLEEPI project

  1. Components and delivery formats of cognitive behavioral therapy for chronic insomnia in adults: a systematic review and component network meta-analysis. JAMA Psychiatry, 2024. doi:10.1001/jamapsychiatry.2023.5060
  2. Initial treatment choices for long-term remission of chronic insomnia disorder in adults: a systematic review and network meta-analysis. Psychiatry and Clinical Neurosciences, 2024. doi:10.1111/pcn.13730
  3. Cognitive behavioral therapy for insomnia to treat major depressive disorder with comorbid insomnia: a systematic review and meta-analysis. Journal of Affective Disorders, 2024. doi:10.1016/j.jad.2024.09.017
A small, focused project run by a researcher who screens records every week. No VC. No sales team. Direct line to the person who writes the code.

Per project, not per person.

Your whole team is included in every plan. Full pricing details.

Free

$0/year
Up to 3 projects · Title/Abstract & full-text screening

Society / Institution

Contact us
Guideline panels, learned societies, networks
Contact us

Questions

Is there a Free plan?

Yes. The Free plan covers up to 3 projects through Title/Abstract and full-text screening — dual review, conflict resolution, and PRISMA flow generation included. Free exports your title/abstract decisions; the full-text screening decision CSV is part of Pro. Pro ($300/yr/project) unlocks PDF storage, full-text retrieval, data extraction, and risk of bias.

Can I export my data?

Screening decisions export as CSV, your reference library as RIS or BibTeX, the PRISMA flow as PNG or PDF, and analysis data as RevMan 5 XML. Extraction and risk-of-bias CSV exports are Pro features and follow your plan. We make reasonable efforts to keep export working, but we do not promise that any one format stays available forever — the commitment we do make is in Terms of Service §4.5.

Where are my PDFs stored?

In your own cloud storage account. SLEEPI connects to your storage — we don't upload your PDFs to our own object storage, they stay in your cloud account.

Can I use it for a standard (non-living) SR?

Yes. A standard SR is a Living SR with one round. All features work the same way.

Can I migrate from other tools?

Your references, yes — import them from RIS or NBIB files exported by any database, and SLEEPI deduplicates them against your later rounds. Screening decisions made in another tool cannot be imported; those have to be re-entered in SLEEPI.

Is my data secure?

Review metadata is stored on secure infrastructure in Tokyo. PDFs remain in your storage. Designed to meet GDPR and APPI requirements. You can request account deletion yourself at any time; your personal data is anonymized after a 14-day grace period. Details are in our Privacy Policy.

Request access.

SLEEPI opens to new teams in waves. Tell us about your review, pricing, or anything else — a person reads every message and replies by email.

Thanks — your message is on its way. We reply by email, usually within a few days.

We could not send your message. Please try again in a moment.

We use your name, email and any affiliation you give only to reply to this message — our legal basis is our legitimate interest in answering you (GDPR Art. 6(1)(f)). Your message is not saved in the app's database; it is kept as email in the operator's mailbox only as long as we need it to answer you and for our records — see our Retention Policy. You are not added to any mailing list. More in our Privacy Policy.